Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply.
作者信息
Bramante Carolyn T, Buse John B, Boulware David R
机构信息
University of Minnesota Medical School, Minneapolis, MN
University of North Carolina at Chapel Hill, Chapel Hill, NC.
出版信息
N Engl J Med. 2022 Dec 15;387(24):e65. doi: 10.1056/NEJMc2212542.
Abstract
摘要
相似文献
1
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply.
N Engl J Med. 2022 Dec 15;387(24):e65. doi: 10.1056/NEJMc2212542.
2
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
N Engl J Med. 2022 Aug 18;387(7):599-610. doi: 10.1056/NEJMoa2201662.
3
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
N Engl J Med. 2022 Dec 15;387(24):e65. doi: 10.1056/NEJMc2212542.
4
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up.
medRxiv. 2022 Dec 23:2022.12.21.22283753. doi: 10.1101/2022.12.21.22283753.
5
COVID-19 update: Metformin to prevent long COVID?
Med Lett Drugs Ther. 2023 May 29;65(1677):87-88. doi: 10.58347/tml.2023.1677e.
6
Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19-Reply.
JAMA. 2023 May 16;329(19):1702-1703. doi: 10.1001/jama.2023.5064.
7
Fluvoxamine for the treatment of COVID-19 - Author's reply.
Lancet Glob Health. 2022 Mar;10(3):e333. doi: 10.1016/S2214-109X(21)00588-X.
8
Effectiveness of fluvoxamine at preventing COVID-19 infection from turning severe.
Eur Neuropsychopharmacol. 2023 Feb;67:83-85. doi: 10.1016/j.euroneuro.2022.12.001. Epub 2022 Dec 13.
9
Lack of Benefit of Fluvoxamine for COVID-19.
JAMA. 2023 Jan 24;329(4):291-292. doi: 10.1001/jama.2022.23954.
10
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial.
Lancet Glob Health. 2022 Jan;10(1):e42-e51. doi: 10.1016/S2214-109X(21)00448-4. Epub 2021 Oct 28.
引用本文的文献
1
Trial Sequential Analysis and Updated Meta-Analysis of Fluvoxamine on Clinical Deterioration in Adult Patients with Symptomatic COVID-19 Infection.
Int J Environ Res Public Health. 2023 Feb 24;20(5):4088. doi: 10.3390/ijerph20054088.
本文引用的文献
1
Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations.
BMC Pharmacol Toxicol. 2022 Jun 18;23(1):41. doi: 10.1186/s40360-022-00580-8.
2
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.
N Engl J Med. 2019 Jan 3;380(1):23-32. doi: 10.1056/NEJMoa1811403. Epub 2018 Nov 10.
3
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.
N Engl J Med. 2019 Jan 3;380(1):33-44. doi: 10.1056/NEJMoa1809944. Epub 2018 Nov 10.
4
The Primary Outcome Fails - What Next?
N Engl J Med. 2016 Sep 1;375(9):861-70. doi: 10.1056/NEJMra1510064.
Zotero 插件